Mekophar Chemical Pharmaceutical

Mekophar Chemical Pharmaceutical Joint Stock Company is a factory.

Company Introduction:

Mekophar Chemical Pharmaceutical Joint Stock Company is a leading pharmaceutical manufacturer based in Vietnam. The company was established in 1975 and transformed into a joint stock company in 2000. Mekophar specializes in the research, manufacturing, trading, import, and export of a diverse range of products including pharmaceuticals, chemicals, raw materials, cosmetic ingredients, food products, and functional foods. With a strong commitment to quality, Mekophar operates under international standards, holding certifications such as GMP (Good Manufacturing Practice), GLP (Good Laboratory Practice), GSP (Good Storage Practice), and ISO 9001, ensuring high-quality production and reliable supply.

Mekophar Chemical Pharmaceutical manufactures and sells a wide array of pharmaceutical products. These include antibiotics such as Ampicillin, Amoxicillin, Cephalexin, Ciprofloxacin, and Azithromycin. The company also produces pain relievers and anti-inflammatory drugs like Paracetamol, Ibuprofen, and Diclofenac. Cardiovascular medications are also part of their portfolio, including Amlodipine and Valsartan. For gastrointestinal issues, they offer products like Omeprazole, Ranitidine, and Domperidone. A range of vitamins and minerals, including various multivitamins and Vitamin C, are available. Antiallergy medications like Loratadine and Cetirizine are produced, alongside respiratory drugs such as Salbutamol and Theophylline. Mekophar additionally provides drugs for diabetes, the nervous system, eyes, ears, nose, and throat, as well as dermatological preparations. Hormonal drugs and traditional medicines are also part of their extensive product line.